16-58026506-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002428.4(MMP15):c.156T>A(p.His52Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000436 in 1,354,260 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002428.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMP15 | NM_002428.4 | c.156T>A | p.His52Gln | missense_variant | 1/10 | ENST00000219271.4 | NP_002419.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMP15 | ENST00000219271.4 | c.156T>A | p.His52Gln | missense_variant | 1/10 | 1 | NM_002428.4 | ENSP00000219271.3 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152172Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000541 AC: 1AN: 18482Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 10886
GnomAD4 exome AF: 0.0000283 AC: 34AN: 1201970Hom.: 0 Cov.: 30 AF XY: 0.0000308 AC XY: 18AN XY: 583830
GnomAD4 genome AF: 0.000164 AC: 25AN: 152290Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2024 | The c.156T>A (p.H52Q) alteration is located in exon 1 (coding exon 1) of the MMP15 gene. This alteration results from a T to A substitution at nucleotide position 156, causing the histidine (H) at amino acid position 52 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at